Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2025-01-03T12:36:40.262Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology and Clonality of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Causing Bacteremia in a Tertiary-Care Hospital in Spain

Published online by Cambridge University Press:  21 June 2016

Fernando Chaves ,
Jesus García-Martínez ,
Sonia de Miguel ,
Francisca Sanz  and
Joaquín R. Otero
Fernando Chaves*
Affiliation:
Servicio de Microbiología, Hospital Universitario Doce de Octubre, Madrid, Spain
Jesus García-Martínez
Affiliation:
Servicio de Microbiología, Hospital Universitario Doce de Octubre, Madrid, Spain
Sonia de Miguel
Affiliation:
Servicio de Microbiología, Hospital Universitario Doce de Octubre, Madrid, Spain
Francisca Sanz
Affiliation:
Servicio de Microbiología, Hospital Universitario Doce de Octubre, Madrid, Spain
Joaquín R. Otero
Affiliation:
Servicio de Microbiología, Hospital Universitario Doce de Octubre, Madrid, Spain
*
Servicio de Microbiología, Hospital Universitario Doce de Octubre, Avenida de Cordoba sn, Madrid 28041, Spain. [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To describe the relative proportions of nosocomial and community-onset Staphylococcus aureus bacteremia at our institution and the epidemiologic characteristics and clonal diversity of S. aureus isolates, as determined by pulsed-field gel electrophoresis (PFGE) and antimicrobial resistance patterns.

Design:

Retrospective cohort study of all cases of S. aureus bacteremia between October 2001 and October 2002.

Setting:

A 1,300-bed, tertiary-care hospital.

Results:

One hundred sixty-two unique episodes of S. aureus bacteremia were identified. Forty-three cases (26.5%) were caused by methicillin-resistant S. aureus (MRSA). Most cases of S. aureus bacteremia, whether MRSA or methicillin susceptible (MSSA), were nosocomial in origin (77.2%) or were otherwise associated with the healthcare system (16%). Only 11 (6.8%) of the cases (all MSSA) were strictly community acquired. Thirty-five unique macrorestriction patterns were identified among the 154 isolates that were typed by PFGE. Four major genotypes were defined among the isolates of MRSA, with 36 (85.7%) represented by a single PFGE type. Of the isolates within this major clone, all (100%) were ciprofloxacin resistant and 77.8% were erythromycin resistant. In contrast, the 112 isolates of MSSA comprised 31 different PFGE types, 3 of which represented 42.9% of all MSSA isolates and were associated with both nosocomial and community-onset bacteremia.

Conclusions:

Most cases of S. aureus bacteremia in our healthcare region are nosocomial in origin or are acquired through contact with the healthcare system and are thus potentially preventable. To preclude dissemination of pathogenic clones, it is therefore necessary to redouble preventive measures in both the hospital and the community.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 2 , February 2005 , pp. 150 - 156
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Cosgrove, SE, Sakoulas, G, Perencevich, EN, Schwaber, MJ, Karchmer, AW, Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53–59.CrossRefGoogle ScholarPubMed
2.Nishi, J, Yoshinaga, M, Miyanohara, H, et al.An epidemiologic survey of methicillin-resistant Staphylococcus aureus by combined use of mec-HVR genotyping and toxin genotyping in a university hospital in Japan. Infect Control Hosp Epidemiol 2002;23:506–510.Google Scholar
3.Seal, JB, Moreira, B, Bethel, CD, Daum, RS. Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol 2003;24:403–408.Google Scholar
4.Chambers, HEThe changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178–182.CrossRefGoogle ScholarPubMed
5.Salgado, CD, Farr, BM, Calfee, DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131–139.Google Scholar
6.Aires de Sousa, M, Crisòstomo, MI, Santos Sanches, I, et al.Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China. J Clin Microbiol 2003;41:159–163.CrossRefGoogle ScholarPubMed
7.Da Silva Coimbra, MV, Silva-Carvalho, MC, Wisplinghoff, H, et al.Clonal spread of methicillin-resistant Staphylococcus aureus in a large geographic area of the United States. J Hosp Infect 2003;53:103–110.Google Scholar
8.Dominguez, MA, Lencastre, H, Linares, J, Tomasz, A. Spread and maintenance of a dominant methicillin-resistant Staphylococcus aureus (MRSA) disease in a Spanish hospital. J Clin Microbiol 1994;32:2081–2087.CrossRefGoogle Scholar
9.Nath, SK, Shea, B, Jackson, S, Rotstein, C. Ribotyping of nosocomial methicillin-resistant Staphylococcus aureus isolates from a Canadian hospital. Infect Control Hosp Epidemiol 1995;15:717–724.Google Scholar
10.van Warnel, WJB, Fluit, AC, Wadström, Van Dijk H, Verhoef, J, Vandenbroucke-Grauls, CMJE. Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1995;33:1769–1774.Google Scholar
11.Landman, D, Bratu, S, Flores, C, et al.Molecular epidemiology of oxacillin-resistant Staphylococcus aureus in Brooklyn, New York. Eur J Clin Microbiol 2003;22:58–61.CrossRefGoogle ScholarPubMed
12.Leski, T, Oliveira, D, Trzcinski, K, et al.Clonal distribution of methicillin-resistant Staphylococcus aureus in Poland. J Clin Microbiol 1998;36: 3532–3539.Google Scholar
13.Simor, AE, Ofner-Agostini, M, Bryce, E, et al.Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of national surveillance, 1995-1999. J Infect Dis 2002;186:652–660.Google Scholar
14.Teixeira, LA, Resende, CA, Ormonde, LR, et al.Geographic spread of epidemic multiresistant Staphylococcus aureus clone in Brazil. J Clin Microbiol 1995;33:2400–2404.Google Scholar
15.van Belkum, A, Van Leeuwen, W, Verkooyen, R, Sacilik, SC, Cokmus, C, Verbrugh, H. Dissemination of a single clone of methicillin-resistant Staphylococcus aureus among Turkish hospitals. J Clin Microbiol 1997; 35:978–981.CrossRefGoogle ScholarPubMed
16.Witte, W, Cuny, C, Zimmermann, O, et al.Stability of genomic DNA fragment patterns in methicillin-resistant Staphylococcus aureus (MRSA) during the course of intra- and interhospital spread. Eur J Epidemiol 1994;10:743–748.Google Scholar
17.Aires de Sousa, M, Santos Sanches, I, Ferro, ML, et al.Intercontinental spread of a multidrug-resistant Staphylococcus aureus clone. J Clin Microbiol 1998;36:2590–2596.Google Scholar
18.Da Silva Coimbra, MV, Teixeira, IA, Ramos, RL, et al.Spread of the Brazilian epidemic clone of a multiresistant MRSA in two cities in Argentina. J Med Microbiol 2000;49:187–192.CrossRefGoogle Scholar
19.Jonas, D, Towner, KJ, Loerwald, M, Shunburne, L, Schmidt-Wieland, T, Daschner, FD. Diversity of Staphylococcus aureus strains isolated from two European regions with different prevalences of methicillin resistance. Eur J Clin Microbiol Infect Dis 2002;21:880–883.Google Scholar
20.Mato, R, Sanches, IS, Venditti, M, Platt, DJ, Brown, A, De Lencastre, H. Spread of the multiresistant Iberian clone of methicillin resistant Staphylococcus aureus (MRSA) to Italy and Scotland. Microb Drug Resist 1998;4:107–112.CrossRefGoogle ScholarPubMed
21.O'Neill, GL, Murchan, S, Gil-Setas, A, Aucken, HM. Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15). J Clin Microbiol 2001; 39:1540–1548.Google Scholar
22.Sá-Leão, R, Santos Sanches, I, Dias, D, Peres, L, Barros, RM, De Lencastre, H. Detection of an archaic clone of Staphylococcus aureus with low-level resistance of methicillin in a pediatric hospital in Portugal and in international samples: relics of a formerly widely disseminated strain? J Clin Microbiol 1999;37:1913–1920.CrossRefGoogle Scholar
23.Sanches, IS, Ramirez, M, Troni, H, et al.Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J Clin Microbiol 1995;33:1243–1246.CrossRefGoogle ScholarPubMed
24.Senna, JPM, Pinto, CA, Mateos, S, Quintana, A, Santos, DS. Spread of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone between Uruguayan and South of Brazil Hospitals. J Hosp Infect 2002;53:156–157.Google Scholar
25.Amyes, SGB, Gemmel, CG. Antibiotic resistance. J Med Microbiol 1997; 46:436–470.CrossRefGoogle ScholarPubMed
26.Enright, MC, Robinson, DA, Rändle, G, Feil, EG, Grundmann, H, Spratt, BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002;99:7687–7692.CrossRefGoogle ScholarPubMed
27.Oliveira, DC, Tomasz, A, De Lencastre, H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002;2:180–189.Google Scholar
28.Grundmann, H, Tami, A, Hori, S, Halwani, M, Slack, R. Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. Br Med J 2002;324:1365–1366.Google Scholar
29.McDonald, P, Mitchell, E, Johnson, H, et al.MRSA bacteraemia: North/South study of MRSA in Ireland 1999. J Hosp Infect 2002;52:288–291.CrossRefGoogle Scholar
30.Public Health Laboratory Service Communicable Disease Surveillance Centre. Staphylococcus aureus bacteraemia: England and Wales, January to December 1999. Communicable Disease Report Weekly 2002;10:23–24.Google Scholar
31.Public Health Laboratory Service. Staphylococcus aureus bacteraemia: England and Wales 2001. Communicable Disease Report Weekly 2001;12:6–22.Google Scholar
32.Public Health Laboratory Service. First report of the Department of Health's mandatory MRSA bacteraemia surveillance scheme in acute NHS Trusts in England: April to September 2001. Communicable Disease Report Weekly 2002;12:1–15.Google Scholar
33.National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, ed. 8. Villanova, PA, National Committee for Clinical Laboratory Standards; 2003. Approved standard M02-A8.Google Scholar
34.Geha, DJ, Uhl, JR, Gustaferro, CA, Persing, DH. Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. J Clin Microbiol 1994;32:1768–1772.Google Scholar
35.Fuchs, PC, Jones, RN, Barry, AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990;28:608–609.Google Scholar
36.Tenover, FC, Arbeit, RD, Goering, RV, et al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.Google Scholar
37.Morin, CA, Hadler, JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001;184:1029–1034.Google Scholar
38.van Dijk, Y, Wielders, CLC, Fluit, AC, Paauw, A, Diepersloot, RJA, Mascini, EL. Genotyping of clinical methicillin-susceptible Staphylococcus aureus isolates in a Dutch teaching hospital. J Clin Microbiol 2002;40:663–665.Google Scholar
39.Von Eiff, C, Becker, K, Machka, K, Stammer, H, Peters, G. Nasal carriage as source of Staphylococcus aureus bacteremia. N Engl J Med 2001;344:11–16.CrossRefGoogle ScholarPubMed